Curative Health Services Enters Into $25 Million Line of Credit; Company Poised for Aggressive Growth through Acquisition.

Business Editors

MINNEAPOLIS--(BUSINESS WIRE)--Feb. 1, 2002

Curative Health Services, Inc. (NASDAQ: CURE) announced today that it has entered into a $25 million line of credit with Healthcare Business Credit Corporation.

Curative intends to use the funds to finance their recently announced acquisition of Apex Therapeutic Care, for anticipated acquisitions and for general operating purposes.

"Establishing this line of credit completes another part of our plan to aggressively grow our Specialty Pharmacy Services (SPS) through acquisition and add new product offerings in the Specialty Healthcare Services business unit," said Curative's Chief Executive Office, Gary Blackford. "With the acquisitions of Hemophilia Access and Apex in January, we will have already exceeded our 2002 goal of 100% revenue growth in the SPS business unit."

About Curative Health Services

Curative Health Services (CURE) delivers superior clinical outcomes and unmatched patient satisfaction for patients experiencing serious medical conditions through two unique business units.

Curative's Specialty Pharmacy Services (SPS) business unit provides patient-centric services that facilitate the health care management process, and provides related pharmacy products for chronic disease states such as Hemophilia. These services are provided directly to patients and caregivers by community-based representatives.

Curative Health Services' Specialty Healthcare Services (SHS) business unit is the undisputed industry leader in chronic wound care management, consistently achieving an outcome success rate of more than 80 percent, more than twice the industry average. Curative provides a broad continuum of services to health care providers through a nationwide network. This national network of more than 100 hospital-based Wound Care Center programs, has offered comprehensive treatment to over 300,000 patients, achieving more than a 95 percent patient satisfaction rate.

For more information, visit www.curative.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include, but are not limited to, the termination or non-renewal of a material number of contracts, an inability to obtain new contracts, changes in the government regulations relating to the Company's Specialty Healthcare Services or Specialty Pharmacy Services business units, changes in the regulations governing third party reimbursements for the Company's services, manufacturing shortages of products sold by Curative's Specialty Pharmacy Services business unit and the other risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Readers of this release are referred to the Company's Annual Report on Form 10-K for the year ended December 31, 2000 for further discussion of these and other factors that could affect future results.